ABI3BP and hepatocellular carcinoma: Immunoblot analysis revealed that overexpression of ABI3BP reduced the phosphorylation of ERK and Akt in both HCC-827 (Figure 4a) and NCI-H460 (Figure 4b) cells, indicating that ABI3BP inhibits the MAPK/ERK pathway.